Tags: shkreli | pharma | quash | congress | subpoena

Martin Shkreli Asks Court to Quash Congressional Subpoena

Image: Martin Shkreli Asks Court to Quash Congressional Subpoena

Saturday, 23 Jan 2016 01:24 PM

Martin Shkreli, the former biotechnology executive facing accusations of securities fraud, wants a federal judge to step in and help him avoid being charged with contempt if he doesn’t appear at a congressional hearing next week.

Shkreli’s lawyers are seeking “guidance” from U.S. District Judge Kiyo Matsumoto in Brooklyn regarding a subpoena he received to testify before the House Oversight and Government Reform Committee at a hearing on drug pricing Jan. 26. The committee said it would pursue criminal contempt charges against him if he does not attend, attorney Marcus Asner said in the letter.

The terms of Shkreli’s $5 million bail package don’t allow him to travel. The former executive, who rose to infamy last year after raising the price of a life-saving drug by more than 5,000 percent, has said he plans to invoke his Fifth Amendment rights. The constitutional amendment protects against self- incrimination.

Shkreli’s lawyers asked Matsumoto to quash or delay the congressional subpoena “if the court decides that Mr. Shkreli may not leave the Eastern and Southern Districts of New York in order to attend the Committee hearing,” according to the filing.

Shkreli received the congressional subpoena on Jan. 12 and has so far made no attempt to request permission from the court to modify his bail terms to allow travel to Washington. The 32- year-old founder of hedge funds and drug companies, notoriously outspoken on social media, tweeted to lawmakers Friday “You want me to go to DC to just say ’I plead the 5th’? For your entertainment?”

Shkreli’s “attendance in person under these circumstances would only serve to subject Mr. Shkreli to embarrassment and obloquy without serving any of the legitimate tasks of Congress,” his lawyers told the congressional committee, according to their letter to Matsumoto.

© Copyright 2017 Bloomberg News. All rights reserved.

 
1Like our page
2Share
Newsfront
Martin Shkreli, the former biotechnology executive facing accusations of securities fraud, is trying to avoid also being charged with contempt if he does not appear at a congressional hearing next week.Shkreli's lawyers filed a letter on Friday asking a federal judge in...
shkreli, pharma, quash, congress, subpoena
293
2016-24-23
Saturday, 23 Jan 2016 01:24 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved